Related Experiment Video
Updated: Aug 13, 2025

Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
Published on: June 13, 2020
Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out
Gabriele Conti1,2, Federica D'Amico1,2, Marco Fabbrini1,2
1Microbiomics Unit, Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Abstract:
Anticancer treatments have shown a variable therapeutic outcome that may be partly attributable to the activity of the gut microbiota on the pathology and/or therapies. In recent years, microbiota-drug interactions have been extensively investigated, but most of the underlying molecular mechanisms still remain unclear. In this review, we discuss the relationship between the gut microbiota and some of the most commonly used drugs in oncological diseases. Different strategies for manipulating the gut microbiota layout (i.e., prebiotics, probiotics, antibiotics, and fecal microbiota transplantation) are then explored in order to optimize clinical outcomes in cancer patients. Anticancer technologies that exploit tumor-associated bacteria to target tumors and biotransform drugs are also briefly discussed. In the field of pharmacomicrobiomics, multi-omics strategies coupled with machine and deep learning are urgently needed to bring to light the interaction among gut microbiota, drugs, and host for the development of truly personalized precision therapies.
Insights
The gut microbiota significantly impacts cancer treatment outcomes. Understanding these interactions is key to developing personalized therapies and improving patient results through microbiota modulation.
Area of Science:
- Oncology
- Microbiology
- Pharmacology
Background:
- Gut microbiota influences cancer pathology and treatment efficacy.
- Mechanisms of microbiota-drug interactions in oncology are not fully understood.
Purpose of the Study:
- To review the relationship between gut microbiota and common anticancer drugs.
- To explore strategies for optimizing cancer treatment through microbiota manipulation.
Main Methods:
- Literature review of microbiota-drug interactions in cancer.
- Discussion of prebiotics, probiotics, antibiotics, and fecal microbiota transplantation.
- Brief overview of tumor-associated bacteria in cancer therapy.
Main Results:
- Gut microbiota activity can affect anticancer treatment outcomes.
- Various strategies exist to modulate the gut microbiota for improved clinical results.
- Exploiting tumor-associated bacteria offers novel therapeutic avenues.
Conclusions:
- Further research using multi-omics and AI is crucial for personalized cancer therapies.
- Understanding host-microbiota-drug interactions will advance precision oncology.
- Targeted microbiota modulation holds promise for enhancing cancer treatment efficacy.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
What is Monogastric Digestion?
Drugs that Stabilize Microtubules
The Tumor Microenvironment
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.

